Page last updated: 2024-08-23

cabergoline and Multiple Primary Neoplasms

cabergoline has been researched along with Multiple Primary Neoplasms in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bolu, E; Kebapcilar, L; Kutlu, M; Sahin, M; Taslipinar, A; Uckaya, G	1
Coiré, CI; Horvath, E; Kovacs, K; Rosso, D; Smyth, HS	1
Bianchi, A; De Marinis, L; Doglietto, F; Giampietro, A; Iacovazzo, D; Lauriola, L; Lucci-Cordisco, E; Lugli, F; Milardi, D	1

Reviews

1 review(s) available for cabergoline and Multiple Primary Neoplasms

Article	Year
Double pituitary adenomas. Endocrine, 2013, Volume: 43, Issue:2 Topics: Adenoma; Antineoplastic Agents; Cabergoline; Combined Modality Therapy; Comorbidity; Ergolines; Humans; Male; Middle Aged; Neoplasms, Multiple Primary; Neurosurgical Procedures; Pituitary ACTH Hypersecretion; Pituitary Neoplasms; Treatment Outcome	2013

Other Studies

2 other study(ies) available for cabergoline and Multiple Primary Neoplasms

Article	Year
Insulin-like growth factor-1 is essential to the increased mortality caused by excess growth hormone: a case of thyroid cancer and non-Hodgkin's lymphoma in a patient with pituitary acromegaly. Medical oncology (Northwood, London, England), 2009, Volume: 26, Issue:1 Topics: Acromegaly; Adenoma; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cabergoline; Cyclophosphamide; Ergolines; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Lymphoma, Non-Hodgkin; Male; Neoplasms, Multiple Primary; Octreotide; Prednisone; Thyroid Neoplasms; Thyroidectomy; Thyroxine; Vincristine	2009
A double pituitary adenoma presenting as a prolactin-secreting tumor with partial response to medical therapy. Case report. Endocrine pathology, 2010, Volume: 21, Issue:2 Topics: Adenoma; Adult; Antineoplastic Agents; Breast Neoplasms, Male; Cabergoline; Combined Modality Therapy; Ergolines; Gonadotrophs; Humans; Male; Microscopy, Electron, Transmission; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Neurofibromatosis 1; Neurosurgical Procedures; Prolactinoma	2010

Article

Year

Insulin-like growth factor-1 is essential to the increased mortality caused by excess growth hormone: a case of thyroid cancer and non-Hodgkin's lymphoma in a patient with pituitary acromegaly.

Medical oncology (Northwood, London, England), 2009, Volume: 26, Issue:1

Topics: Acromegaly; Adenoma; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cabergoline; Cyclophosphamide; Ergolines; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Lymphoma, Non-Hodgkin; Male; Neoplasms, Multiple Primary; Octreotide; Prednisone; Thyroid Neoplasms; Thyroidectomy; Thyroxine; Vincristine

2009

A double pituitary adenoma presenting as a prolactin-secreting tumor with partial response to medical therapy. Case report.

Endocrine pathology, 2010, Volume: 21, Issue:2

Topics: Adenoma; Adult; Antineoplastic Agents; Breast Neoplasms, Male; Cabergoline; Combined Modality Therapy; Ergolines; Gonadotrophs; Humans; Male; Microscopy, Electron, Transmission; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Neurofibromatosis 1; Neurosurgical Procedures; Prolactinoma

2010